Summary of the OECD Guideline for Testing Chemicals: Rapid Estrogen Activity In Vivo (REACTIV) Assay
The OECD Guideline for Testing Chemicals: Rapid Estrogen Activity In Vivo (REACTIV) Assay provides a methodology for identifying chemicals that are active on the estrogen axis through an aquatic assay utilizing transgenic Oryzias latipes (Japanese medaka) eleutheroembryos. This assay aims to serve as a screening tool offering a medium throughput and short-term measurement of chemical responses in the medaka embryos.
Key Points:
-
Assay Design: The REACTIV assay employs a transgenic line of Japanese medaka fish that expresses Green Fluorescent Protein (GFP) in response to estrogen axis signaling, specifically through the choriogenin H gene promoter. This promoter region contains potential estrogen response elements (ERE), enabling modulation of GFP expression in the presence of estrogen receptor (ER) agonists, antagonists, or compounds affecting steroidogenic enzymes.
-
Species Selection: Oryzias latipes is chosen due to its utilization in multiple OECD validated tests, including toxicity assessments across various life stages.
-
Endpoint Measurement: The primary endpoint is fluorescence in the liver of the eleutheroembryos. Exposure to a test chemical results in increased or decreased fluorescence compared to unexposed controls.
-
Test Conditions: The assay includes the addition of 30 μg/L of testosterone (T) to the test medium to facilitate the detection of substances affecting T availability or antagonizing ERs, as T is converted to estradiol by the cytochrome P450 enzyme aromatase (CYP19).
-
Validation and Limitations: The REACTIV assay was validated through an international interlaboratory study involving 18 test substances across six laboratories. The assay is sensitive to a range of mechanisms including ER agonists, selective estrogen response modulators, and modulators of steroidogenesis. However, it does not detect non-genomic actions of estrogen, such as rapid signaling through membrane-localized ER.
-
Implementation Considerations: The use of the REACTIV assay requires specific transgenic lines and adherence to guidelines for the use of transgenic organisms. Other transgenic lines not validated under OECD criteria cannot be used for this assay.
In summary, the REACTIV assay offers a robust tool for preliminary screening of chemicals' estrogenic activity in medaka embryos, providing insights into their impact on the estrogen axis through quantifiable changes in GFP fluorescence. However, limitations in detecting non-genomic actions highlight the need for complementary testing strategies.
